Breaking News

Pharma loses a key battle over a state law concerning 340B pharmacies; Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients?

March 13, 2024
Pharmalot Columnist, Senior Writer
Adobe

STAT+ | Pharma loses a key battle over a state law concerning 340B pharmacies

The pharmaceutical industry argued that hospitals that rely on contract pharmacies are abusing a U.S. drug discount program.

By Ed Silverman


STAT+ | Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients?

Researchers spent 40 years and billions of dollars developing gene therapies. But now that they're approved, many patients don't want them.

By Jason Mast


After Amylyx ALS trial failure, patients share disappointment and fear — but some hope

ALS patients worry failed trial could impact future drug development, fear loss of insurance coverage. And yet they're clinging onto hope.

By Annalisa Merelli



More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Pharmalot? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments